Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(50%)
Terminated
1(50%)

Phase Distribution

Ph not_applicable
1
50%
Ph phase_4
1
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Terminated(1)

Detailed Status

Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

active_not_recruiting150%
terminated150%

Recent Activity

1 active trials
Showing 2 of 2
active_not_recruitingnot_applicable

A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wrinkles, Fine Lines, and Dark Spots.

NCT07111156
terminatedphase_4

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

NCT00810862

Clinical Trials (2)

Showing 2 of 2 trials
NCT07111156Not Applicable

A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wrinkles, Fine Lines, and Dark Spots.

Active Not Recruiting
NCT00810862Phase 4

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

Terminated

All 2 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
2